1.

Record Nr.

UNINA9910329360403321

Autore

Bolognini, Silvio

Titolo

Il  paradigma della globalizzazione giuspolitica comunitaria : morfologia e criticità dei fattori di omogeneizzazione / Silvio Bolognini

Pubbl/distr/stampa

Milano : Giuffrè, 2018

ISBN

978-88-28-80937-1

Descrizione fisica

IX, 503 p. ; 24 cm

Collana

Scienza giuridica e politiche del diritto ; 3

Disciplina

349.24

Locazione

DECBC

Collocazione

GRDDCE64A

Lingua di pubblicazione

Italiano

Formato

Materiale a stampa

Livello bibliografico

Monografia



2.

Record Nr.

UNISA996320209203316

Autore

Laxminarayan Ramanan

Titolo

Extending the cure : policy responses to the growing threat of antibiotic resistance / / Ramanan Laxminarayan and Anup Malani ; with David Howard and David L. Smith

Pubbl/distr/stampa

Washington, D.C. : , : Resources for the Future, , 2007

ISBN

1-136-52759-1

1-280-68706-1

9786613664006

1-136-52760-5

1-936331-08-X

Descrizione fisica

1 online resource (193 p.)

Altri autori (Persone)

HowardDavid

MalaniAnup

SmithDavid L

Disciplina

614.57

616.9/041

Soggetti

Drug resistance in microorganisms - United States

Drug resistance in microorganisms - Government policy - United States

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references.

Nota di contenuto

Antibiotic resistance: the unfolding crisis / Ramanan Laxminarayan -- The epidemiology of antibiotic resistance: policy levers / David Smith -- Patient and physician demand for antibiotics / David Howard -- The role of health care facilities / Ramanan Laxminarayan -- The role of federal government / Ramanan Laxminarayan -- The role of health insurance / Anup Malani -- Supply-side strategies for tackling resistance / Anup Malani -- Next steps / Ramanan Laxminarayan.

Sommario/riassunto

Our ability to treat common bacterial infections with antibiotics goes back only 65 years. However, the authors of this report make it clear that sustaining a supply of effective and affordable antibiotics cannot be without changes to the incentives facing patients, physicians, hospitals, insurers, and pharmaceutical manufacturers. In fact, increasing resistance to these drugs is already exacting a terrible price.



Every day in the United States, approximately 172 men, women, and children die from infections caused by antibiotic-resistant bacteria in hospitals alone. Beyond those deaths, antibi